Ladrx Corporation (LADX)
:LADX
US Market
Advertisement

LadRx (LADX) Price & Analysis

Compare
370 Followers

LADX Stock Chart & Stats

$0.65
$0.00(0.00%)
At close: 4:00 PM EST
$0.65
$0.00(0.00%)

LADX FAQ

What was Ladrx Corporation’s price range in the past 12 months?
Ladrx Corporation lowest stock price was $0.09 and its highest was $2.80 in the past 12 months.
    What is Ladrx Corporation’s market cap?
    Ladrx Corporation’s market cap is $54.46K.
      When is Ladrx Corporation’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Ladrx Corporation’s earnings last quarter?
      Currently, no data Available
      Is Ladrx Corporation overvalued?
      According to Wall Street analysts Ladrx Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Ladrx Corporation pay dividends?
        Ladrx Corporation does not currently pay dividends.
        What is Ladrx Corporation’s EPS estimate?
        Ladrx Corporation’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Ladrx Corporation have?
        Ladrx Corporation has 495,092 shares outstanding.
          What happened to Ladrx Corporation’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Ladrx Corporation?
          Currently, no hedge funds are holding shares in LADX

          Company Description

          Ladrx Corporation

          LadRx (LADX) is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Operating within the pharmaceutical and healthcare sectors, the company leverages its proprietary technology platforms to create novel drug candidates aimed at addressing unmet medical needs in oncology.
          Similar Stocks
          Company
          Price & Change
          Follow
          Biodexa Pharmaceuticals
          Q/C Technologies
          Salarius Pharmaceuticals
          Scinai Immunotherapeutics
          Oragenics

          Ownership Overview

          <0.01%100.00%
          Insiders
          <0.01% Other Institutional Investors
          100.00% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis